Castleview Partners, LLC Viatris Inc Transaction History

Castleview Partners, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$11.27 - $13.53 $135 - $162	-12 Reduced 33.33%	24 $0
Q3 2023 Oct 26, 2023	SELL	$9.59 - $11.35 $613 - $726	-64 Reduced 64.0%	36 $0
Q2 2023 Aug 14, 2023	SELL	$9.02 - $10.29 $2,327 - $2,654	-258 Reduced 72.07%	100 $0
Q4 2022 Feb 01, 2023	BUY	$8.72 - $11.56 $235 - $312	27 Added 8.16%	358 $3,000
Q3 2022 Nov 10, 2022	SELL	$8.48 - $11.13 $3,129 - $4,106	-369 Reduced 52.71%	331 $3,000
Q2 2022 Aug 17, 2022	SELL	$9.95 - $12.27 $40,426 - $49,853	-4,063 Reduced 85.3%	700 $7,000
Q2 2022 Aug 16, 2022	BUY	$9.95 - $12.27 $42,864 - $52,859	4,308 Added 946.81%	4,763 $49,000
Q1 2022 May 16, 2022	SELL	$9.81 - $15.4 $305,718 - $479,925	-31,164 Reduced 98.56%	455 $4,000
Q4 2021 Feb 17, 2022	BUY	$12.09 - $14.68 $351,553 - $426,865	29,078 Added 1144.35%	31,619 $427,000
Q2 2021 Aug 17, 2021	BUY	$12.97 - $16.15 $32,956 - $41,037	2,541 New	2,541 $36,000

1,096

964M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.4B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Castleview Partners, LLC with notifications on news.